Skip to main content
. 2015 Jun 23;15(9):1017–1023. doi: 10.1016/S1473-3099(15)00061-4

Table 2.

Changes in malaria indicators from 2013 to 2014 at surveyed health facilities, stratified by time and zone

Ebola-unaffected prefectures from 2013 to 2014
Ebola-affected prefectures from 2013 to 2014
January to March April to July August to November January to March April to July August to November
Adults and children (age ≥5 years)
All-cause patient visits 5% 10% −6% 10% −22% −42%
Fever cases −2% 12% −16% −2% −32% −46%
Tested for malaria 73% 80% 23% 32% −9% −23%
Confirmed cases of malaria 72% 75% 36% 32% −21% −35%
Treated with oral antimalarial drugs −13% 8% −21% −21% −42% −58%
Treated with injectable antimalarial drugs −12% 21% −17% −40% −44% −69%
Children (age <5 years)
All-cause patient visits 7% 18% −17% −16% −9% −17%
Fever cases 9% 18% −21% −4% −17% −24%
Tested for malaria 63% 77% 27% 37% 20% 7%
Confirmed cases of malaria 54% 57% 39% 22% 26% 0%
Treated with oral antimalarial drugs −4% 15% −19% −8% −19% −35%
Treated with injectable antimalarial drugs −22% −24% −28% −25% −24% −62%
Pregnant women
Antenatal visits 4% 9% 14% 4% 6% −26%
Doses of sulfadoxine-pyrimethamine given during antenatal clinic visits 28% 33% 15% 37% 59% 37%

Numbers used to calculate the percentage changes are reported in the appendix.